1887

Chapter 9 : Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815820/9781555814083_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555815820/9781555814083_Chap09-2.gif

Abstract:

Rates of early mortality, within the first week after the onset of illness, have remained high for over 40 years, suggesting that, despite the availability of potent antimicrobials and intensive care support, prevention must be the keystone of the effective control of pneumococcal disease. A multivariate analysis of 129 adults hospitalized with community-acquired pneumococcal pneumonia in Edmonton, Canada, identified a history of smoking, fever, myalgia, chest pain, altered mental state, abdominal pain, and tachycardia as significant predictors of bacteremia. The presence of radiographic findings is key in establishing the diagnosis of pneumonia. Physicians may overdiagnose pneumonia based on patient histories and physical findings alone. With Gram staining and culture of expectorated sputum, rates of pathogen detection in comprehensive epidemiologic studies of CAP are only 30 to 50%, often with paired acute and convalescent serology for atypical organisms. The isolation of from cultures of specimens from normally sterile sites is relatively insensitive. Pneumococcal surface adhesin A (PsaA) is a conserved and highly immunogenic protein of expressed at the cell surface in all 90 pneumococcal serotypes. Underlying malignancy (both pulmonary and extrapulmonary) and the absence of fever also predicted lethal infection in most of the studies in which the variables were examined. The goal for clinicians and patients is improved survival, the more rapid resolution of disease and thus decreased need for admission and decreased length of hospital stays, and decreased cost.

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9

Key Concept Ranking

Chronic Obstructive Pulmonary Disorder
0.43426618
0.43426618
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Incidence of hospitalization for CAP and mortality by age, Ohio, 1991 ( ).

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Right lower lobe consolidation with pneumococcal pneumonia; posterior-anterior (left) and lateral (right) views.

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Sensitivity of sputum culture for diagnosis of pneumococcal pneumonia. Data are listed by first authors of the studies reporting the results ( ). 95% CI, 95% confidence interval.

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815820.ch09
1. Afessa, B.,, W. L. Greaves, and, W. R. Frederick. 1995. Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin. Infect. Dis. 21:345351.
2. Ailani, R. K.,, A. Alimchandani,, J. Hidalgo,, R. Ailani,, J. Buckley, and, B. DiGiovine. 2002. Cephalosporin-resistant pneumococcal pneumonia: does it affect outcome? Respir. Med. 96:805811.
3. Amsden, G. W. 1999. Pneumococcal macrolide resistance –myth or reality? J. Antimicrob. Chemother. 44:16.
4. Anderson, K. B.,, J. S. Tan,, T. M. File, Jr.,, J. R. DiPersio,, B. M. Willey, and, D. E. Low. 2003. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. Clin. Infect. Dis. 37:376381.
5. Andreo, F.,, J. Dominguez,, J. Ruiz,, S. Blanco,, E. Arellano,, C. Prat,, J. Morera, and, V. Ausina. 2006. Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults. Respir. Med. 100:884891.
6. Apisarnthanarak, A., and, L. M. Mundy. 2005. Etiology of community-acquired pneumonia. Clin. Chest Med. 26:4755.
7. Aspa, J.,, O. Rajas,, F. Rodriguez de Castro,, J. Blanquer,, R. Zalacain,, A. Fenoll,, R. de Celis,, A. Vargas,, F. Rodriguez Salvanes,, P. P. Espana,, J. Rello, and, A. Torres. 2004. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin. Infect. Dis. 38:787798.
8. Aspa, J.,, O. Rajas,, F. Rodriguez de Castro,, M. C. Huertas,, L. Borderias,, F. J. Cabello,, J. Tabara,, S. Hernandez-Flix,, A. Martinez-Sanchis, and, A. Torres. 2006. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur. Respir. J. 27:10101019.
9. Austrian, R., and, J. Gold. 1964. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60:759776.
10. Barrett-Connor, E. 1971. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am. Rev. Respir. Dis. 103:845848.
11. Bartlett, J. G., and, L. M. Mundy. 1995. Community-acquired pneumonia. N. Engl. J. Med. 333:16181624.
12. Bennett, N. M.,, J. Buffington, and, F. M. La Force. 1992. Pneumococcal bacteremia in Monroe County, New York. Am. J. Public Health 82:15131516.
13. Bodi, M.,, A. Rodriguez,, J. Sole-Violan,, M. C. Gilavert,, J. Garnacho,, J. Blanquer,, J. Jimenez,, M. V. de la Torre,, J. M. Sirvent,, J. Almirall,, A. Doblas,, J. R. Badia,, F. Garcia,, A. Mendia,, R. Jorda,, F. Bobillo,, J. Valles,, M. J. Broch,, N. Carrasco,, M. A. Herranz, and, J. Rello. 2005. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin. Infect. Dis. 41:17091716.
14. Bonnard, P.,, F. X. Lescure,, Y. Douadi,, J. L. Schmit,, V. Jounieaux,, G. Laurans,, F. Eb, and, J. P. Ducroix. 2005. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome. J. Infect. 51:6976.
15. Boudewijns, M.,, J. M. Bakkers,, P. D. Sturm, and, W. J. Melchers. 2006. 16S rRNA gene sequencing and the routine clinical microbiology laboratory: a perfect marriage? J. Clin. Microbiol. 44:34693470.
16. Boulware, D. R.,, C. L. Daley,, C. Merrifield,, P. C. Hopewell, and, E. N. Janoff. 2007. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J. Infect. 55:300309.
17. Brandenburg, J. A.,, T. J. Marrie,, C. M. Coley,, D. E. Singer,, D. S. Obrosky,, W. N. Kapoor, and, M. J. Fine. 2000. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J. Gen. Intern. Med. 15:638646.
18. Breiman, R. F.,, J. S. Spika,, V. J. Navarro,, P. M. Darden, and, C. P. Darby. 1990. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch. Intern. Med. 150:14011405.
19. Briones, M. L.,, J. Blanquer,, D. Ferrando,, M. L. Blasco,, C. Gimeno, and, J. Marin. 2006. Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clin. Vaccine Immunol. 13:10921097.
20. Bruyn, G. A. W.,, J. W. M. van der Meer,, J. Hermans, and, W. Knoppert. 1988. Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden. Rev. Infect. Dis. 10:446450.
21. Burel, E.,, P. Dufour,, V. Gauduchon,, S. Jarraud, and, J. Etienne. 2001. Evaluation of a rapid immunochromatographic assay for detection of Streptococcus pneumoniae antigen in urine samples. Eur. J. Clin. Microbiol. Infect. Dis. 20:840841.
22. Burman, L. Å.,, R. Norrby, and, B. Trollfors. 1985. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev. Infect. Dis. 7:133142.
23. Campbell, J. F.,, M. A. Donohue,, R. B. Mochizuki,, C. L. Nevin-Woods, and, J. S. Spika. 1989. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Med. J. 48:513–514, 517518.
24. Centers for Disease Control and Prevention. 1999. Surveillance for selected public health indicators affecting older adults–United States. Morb. Mortal. Wkly. Rep. Recomm. Rep. 48:5558.
25. Chang, J. I., and, J. M. Mylotte. 1987. Pneumococcal bacteremia: update from an adult hospital with a high rate of nosocomial cases. J. Am. Geriatr. Soc. 35:747754.
26. Chen, C. C.,, L. J. Teng, and, T. C. Chang. 2004. Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region. J. Clin. Microbiol. 42:26512657.
27. Chi, R. C.,, L. A. Jackson, and, K. M. Neuzil. 2006. Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia. J. Am. Geriatr. Soc. 54:115120.
28. Cutts, F. T.,, S. M. Zaman,, G. Enwere,, S. Jaffar,, O. S. Levine,, J. B. Okoko,, C. Oluwalana,, A. Vaughan,, S. K. Obaro,, A. Leach,, K. P. McAdam,, E. Biney,, M. Saaka,, U. Onwuchekwa,, F. Yallop,, N. F. Pierce,, B. M. Greenwood, and, R. A. Adegbola. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365:11391146.
29. Davidson, M.,, B. Tempest, and, D. L. Palmer. 1976. Bacteriologic diagnosis of acute pneumonia: comparison of sputum, transtracheal aspirates, and lung aspirates. JAMA 235:158163.
30. Davidson, R.,, R. Cavalcanti,, J. L. Brunton,, D. J. Bast,, J. C. de Azavedo,, P. Kibsey,, C. Fleming, and, D. E. Low. 2002. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:747750.
31. Dominguez, J.,, N. Gali,, S. Blanco,, P. Pedroso,, C. Prat,, L. Matas, and, V. Ausina. 2001. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 119:243249.
32. Drew, W. L. 1977. Value of sputum culture in diagnosis of pneumococcal pneumonia. J. Clin. Microbiol. 6:6265.
33. Dunbar, L. M.,, R. G. Wunderink,, M. P. Habib,, L. G. Smith,, A. M. Tennenberg,, M. M. Khashab,, B. A. Wiesinger,, J. X. Xiang,, N. Zadeikis, and, J. B. Kahn. 2003. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin. Infect. Dis. 37:752760.
34. El El, R.,, B. C. Opmeer,, P. M. Bossuyt,, P. Speelman,, C. A. de Borgie, and, J. M. Prins. 2004. Development and validation of a short questionnaire in community acquired pneumonia. Thorax 59:591595.
35. El Solh, A. A.,, A. T. Aquilina,, H. Gunen, and, F. Ramadan. 2004. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J. Am. Geriatr. Soc. 52:224229.
36. Farina, C.,, M. Arosio,, F. Vailati,, F. Moioli, and, A. Goglio. 2002. Urinary detection of Streptococcus pneumoniae antigen for diagnosis of pneumonia. New Microbiol. 25:259263.
37. Farinas-Alvarez, C.,, M. C. Farinas,, J. D. Garcia-Palomo,, M. Gonzalez-Ruiz,, C. Fernandez-Mazarrasa,, J. A. Parra, and, J. Gonzalez-Macias. 2000. Prognostic factors for pneumococcal bacteremia in a university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 19:733741.
38. Farr, B. M., and, G. L. Mandell. 1988. Gram-Positive Pneumonia, 2nd ed. Raven Press, New York, NY.
39. Feldman, C. 2004. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J. Lab. Clin. Med. 143:269283.
40. Feldman, C.,, H. Sacho,, H. Levy,, J. M. Kallenbach, and, H. J. Koornhof. 1988. Pneumococcal bacteraemia in adults in a low socio-economic urban population. Q. J. Med. 69:961971.
41. Fiala, M. 1969. A study of the combined role of viruses, mycoplasmas and bacteria in adult pneumonia. Am. J. Med. Sci. 257:4451.
42. File, T. M., Jr., and, M. S. Niederman. 2004. Antimicrobial therapy of community-acquired pneumonia. Infect. Dis. Clin. N. Am. 18:9931016, xi.
43. File, T. M., Jr., and, J. S. Tan. 2005. Optimizing therapy for community-acquired pneumonia with the goal of rapid resolution of illness. Clin. Infect. Dis. 41:17061708.
44. Finch, R.,, D. Schurmann,, O. Collins,, R. Kubin,, J. McGivern,, H. Bobbaers,, J. L. Izquierdo,, P. Nikolaides,, F. Ogundare,, R. Raz,, P. Zuck, and, G. Hoeffken. 2002. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob. Agents. Chemother. 46:17461754.
45. Fine, M. J.,, T. E. Auble,, D. M. Yealy,, B. H. Hanusa,, L. A. Weissfeld,, D. E. Singer,, C. M. Coley,, T. J. Marrie, and, W. N. Kapoor. 1997. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336:243250.
46. Fine, M. J.,, B. H. Hanusa,, J. R. Lave,, D. E. Singer,, R. A. Stone,, L. A. Weissfeld,, C. M. Coley,, T. J. Marrie, and, W. N. Kapoor. 1995. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J. Gen. Intern. Med. 10:359368.
47. Fine, M. J.,, D. E. Singer,, B. H. Hanusa,, J. R. Lave, and, W. N. Kapoor. 1993. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am. J. Med. 94:153159.
48. Fine, M. J.,, M. A. Smith,, C. A. Carson,, S. S. Mutha,, S. S. Sankey,, L. A. Weissfeld, and, W. N. Kapoor. 1996. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 275:134141.
49. Finkelstein, M. S.,, W. M. Petkun,, M. L. Freedman, and, S. C. Antopol. 1983. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J. Am. Geriatr. Soc. 31:1927.
50. Frankel, R. E.,, M. Virata,, C. Hardalo,, F. L. Altice, and, G. Friedland. 1996. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin. Infect. Dis. 23:577584.
51. Frei, C. R.,, J. M. Koeller,, D. S. Burgess,, R. L. Talbert, and, M. T. Johnsrud. 2003. Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project. Pharmacotherapy 23:11671174.
52. Fuller, J. D., and, D. E. Low. 2005. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin. Infect. Dis. 41:118121.
53. Garau, J.,, L. Aguilar,, M. Rodriguez-Creixems,, R. Dal-re,, E. Perez-Trallero,, M. Rodriguez, and, E. Bouza. 1999. Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with beta-lactam monotherapy. J. Chemother. 11:266272.
54. Garcia Vazquez, E.,, J. Mensa,, J. A. Martinez,, M. A. Marcos,, J. Puig,, M. Ortega, and, A. Torres. 2005. Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. Eur. J. Clin. Microbiol. Infect. Dis. 24:190195.
55. Genne, D.,, H. H. Siegrist, and, R. Lienhard. 2006. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Bi-nax NOW). Int. J. Infect. Dis. 10:124128.
56. Gentile, J. H.,, M. D. Sparo,, M. E. Mercapide, and, C. M. Luna. 2003. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients. Medicina (Buenos Aires) 63:914.
57. Gleckman, R.,, J. DeVita,, D. Hibert,, C. Pelletier, and, R. Martin. 1988. Sputum Gram stain assessment in community-acquired bacteremic pneumonia. J. Clin. Microbiol. 26:846849.
58. Gransden, W. R.,, S. J. Eykyn, and, I. Phillips. 1985. Pneumococcal bacteremia: 325 episodes at St. Thomas's hospital. Br. Med. J. 290:505508.
59. Gutierrez, F.,, M. Masia,, J. C. Rodriguez,, A. Ayelo,, B. Soldan,, L. Cebrian,, C. Mirete,, G. Royo, and, A. M. Hidalgo. 2003. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin. Infect. Dis. 36:286292.
60. Guzzetta, P.,, G. B. Toews,, K. J. Robertson, and, A. K. Pierce. 1983. Rapid diagnosis of community-acquired bacterial pneumonia. Am. Rev. Respir. Dis. 128:461464.
61. Halm, E. A.,, M. J. Fine,, T. J. Marrie,, C. M. Coley,, W. N. Kapoor,, D. S. Obrosky, and, D. E. Singer. 1998. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 279:14521457.
62. Harrison, L. H.,, D. M. Dwyer,, L. Billmann,, M. S. Kolczak, and, A. Schuchat. 2000. Invasive pneumococcal infection in Baltimore, Md.: implications for immunization policy. Arch. Intern. Med. 160:8994.
63. Hashikita, G.,, T. Yamaguti,, Y. Tachi,, E. Kishi,, T. Kawamura,, S. Takahashi,, Y. Arai,, S. Koyama,, T. Huruhata,, A. Itabashi,, Y. Oka,, T. Yamazaki, and, S. Maesaki. 2005. [Examination about utility of a Streptococcus pneumoniae capsular antigen swiftness search kit urine in a pneumonia patient.] Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi 16:153161. (In Japanese.)
64. Heffron, R. 1938. Pneumonia, with Special Reference to Pneumococcus Lobar Pneumonia. Harvard University Press, Cambridge, MA.
65. Hibbs, J. R.,, J. M. Douglas, Jr.,, F. N. Judson,, W. L. McGill,, C. A. M. Rietmeijer, and, E. N. Janoff. 1997. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984–1994. Clin. Infect. Dis. 25:195199.
66. Honore, S.,, M. Trillard,, Z. Ould-Hocine,, P. Lesprit,, L. Deforges, and, P. Legrand. 2004. [Contribution of urinary pneumococcal antigen detection combined with the research of legionella antigen for diagnosis of pneumonia in hospitalized patients.] Pathol. Biol. (Paris) 52:429433. (In French.)
67. Hook, E. W. I.,, C. A. Horton, and, D. R. Schaberg. 1983. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 249:10551057.
68. Ioachimescu, O. C.,, A. G. Ioachimescu, and, P. B. Iannini. 2004. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Int. J. Antimicrob. Agents 24:485490.
69. Ishida, T.,, T. Hashimoto,, M. Arita,, Y. Tojo,, H. Tachibana, and, M. Jinnai. 2004. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J. Infect. Chemother. 10:359363.
70. Jado, I.,, A. Fenoll,, J. Casal, and, A. Perez. 2001. Identification of the psaA gene, coding for pneumococcal surface adhesin A, in viridans group streptococci other than Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 8:895898.
71. Janoff, E. N.,, R. F. Breiman,, C. L. Daley, and, P. C. Hopewell. 1992. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann. Intern. Med. 117:314324.
72. Janoff, E. N.,, J. O'Brien,, P. Thompson,, J. Ehret,, G. Meiklejohn,, G. Duvall, and, J. M. Douglas, Jr. 1993. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J. Infect. Dis. 167:4956.
73. Janoff, E. N., and, J. B. Rubins. 2000. Invasive Pneumococcal Disease in Immunocompromised Patients. Mary Ann Liebert, Inc., Larchmont, NY.
74. Janssens, J. P., and, K. H. Krause. 2004. Pneumonia in the very old. Lancet Infect. Dis. 4:112124.
75. Jay, S. J.,, W. G. Johanson, Jr., and, A. K. Pierce. 1975. The radiographic resolution of Streptococcus pneumoniae pneumonia. N. Engl. J. Med. 293:798801.
76. Kalin, M. 1982. Bacteremic pneumococcal pneumonia: value of culture of nasopharyngeal specimens and examination of washed sputum specimens. Eur. J. Clin. Microbiol. 1:394396.
77. Kantor, H. G. 1981. The many radiologic faces of pneumococcal pneumonia. AJR Am. J. Roentgenol. 137:12131220.
78. Kobayashi, T.,, T. Matsumoto,, K. Tateda,, K. Isogai,, K. Kimura,, K. Uchida,, H. Kashitani,, K. Yoshida,, Y. Shinozawa,, T. Kashiyama,, T. Nakatani, and, K. Yamaguchi. 2002. [Evaluation of Streptococcus pneumoniae-urinary antigen detection kit in patients with community acquired pneumonia.] Kansenshogaku Zasshi 76:9951002. (In Japanese.)
79. Kozak, L. J.,, M. F. Owings, and, M. J. Hall. 2005. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 13:1199.
80. Kramer, M. R.,, B. Rudensky,, I. Hadas-Halperin,, M. Isacsohn, and, E. Melzer. 1987. Pneumococcal bacteremia–no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr. J. Med. Sci. 23:174180.
81. Krumholz, H. M.,, M. A. Sande, and, B. Lo. 1989. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology and outcome. Am. J. Med. 86:776779.
82. Kuikka, A.,, J. Syrjanen,, O. V. Renkonen, and, V. V. Valtonen. 1992. Pneumococcal bacteraemia during a recent decade. J. Infect. 24:157168.
83. Leatherman, J. W.,, C. Iber, and, S. F. Davies. 1984. Cavitation in bacteremic pneumococcal pneumonia. Causal role of mixed infection with anaerobic bacteria. Am. Rev. Respir. Dis. 129:317321.
84. Le Monnier, A.,, E. Carbonnelle,, J. R. Zahar,, M. Le Bourgeois,, E. Abachin,, G. Quesne,, E. Varon,, P. Descamps,, J. De Blic,, P. Scheinmann,, P. Berche, and, A. Ferroni. 2006. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin. Infect. Dis. 42:11351140.
85. Lim, I.,, D. R. Shaw,, D. P. Stanley,, R. Lumb, and, G. McLennan. 1989. A prospective hospital study of the aetiology of community-acquired pneumonia. Med. J. Aust. 151:8791.
86. Lim, W. S.,, M. M. van der Eerden,, R. Laing,, W. G. Boersma,, N. Karalus,, G. I. Town,, S. A. Lewis, and, J. T. MacFarlane. 2003. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377382.
87. Lonks, J. R.,, J. Garau,, L. Gomez,, M. Xercavins,, A. Ochoa de Echaguen,, I. F. Gareen,, P. T. Reiss, and, A. A. Medeiros. 2002. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 35:556564.
88. Lorente, M. L.,, M. Falguera,, A. Nogues,, A. R. Gonzalez,, M. T. Merino, and, M. R. Caballero. 2000. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study. Thorax 55:133137.
89. Mandell, L. A.,, T. J. Marrie,, R. F. Grossman,, A. W. Chow,, R. H. Hyland, et al. 2000. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin. Infect. Dis. 31:383421.
90. Mandell, L. A.,, R. G. Wunderink,, A. Anzueto,, J. G. Bartlett,, G. D. Campbell,, N. C. Dean,, S. F. Dowell,, T. M. File, Jr.,, D. M. Musher,, M. S. Niederman,, A. Torres, and, C. G. Whitney. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl. 2):S27–S72.
91. Marcos, M. A.,, M. T. Jimenez de Anta,, J. P. de la Bellacasa,, J. Gonzalez,, E. Martinez,, E. Garcia,, J. Mensa,, A. de Roux, and, A. Torres. 2003. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur. Respir. J. 21:209214.
92. Marfin, A. A.,, J. Sporrer,, P. S. Moore, and, A. D. Siefkin. 1995. Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest 107:457462.
93. Margolin, D. H.,, K. A. Reimann,, J. Sodroski,, G. B. Karlsson,, K. Tenner-Racz,, P. Racz, and, N. L. Letvin. 1997. Immunoglobulin VH usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. J. Virol. 71:85828591.
94. Marrie, T. J. 1999. Pneumococcal pneumonia: epidemiology and clinical features. Semin. Respir. Infect. 14:227236.
95. Marston, B. J.,, J. F. Plouffe,, T. M. File, Jr.,, B. A. Hackman,, S. J. Salstrom,, H. B. Lipman,, M. S. Kolczak,, R. F. Breiman, et al. 1997. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch. Intern. Med. 157:17091718.
96. Menendez, R.,, A. Torres,, F. Rodriguez de Castro,, R. Zalacain,, J. Aspa,, J. J. Martin Villasclaras,, L. Borderias,, J. M. Benitez Moya,, J. Ruiz-Manzano,, J. Blanquer,, D. Perez,, C. Puzo,, F. Sanchez-Gascon,, J. Gallardo,, C. J. Alvarez, and, L. Molinos. 2004. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin. Infect. Dis. 39:17831790.
97. Mirzanejad, Y.,, S. Roman,, J. Talbot,, L. Nicolle,, Y. Mirzanejad,, S. Roman,, J. Talbot,, L. Nicolle, et al. 1996. Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Chest 109:173178.
98. Moine, P.,, J. B. Vercken,, S. Chevret,, P. Gajdos, et al. 1995. Severe community-acquired pneumococcal pneumonia. Scand. J. Infect. Dis. 27:201206.
99. Moroney, J. F.,, A. E. Fiore,, L. H. Harrison,, J. E. Patterson,, M. M. Farley,, J. H. Jorgensen,, M. Phelan,, R. R. Facklam,, M. S. Cetron,, R. F. Breiman,, M. Kolczak, and, A. Schuchat. 2001. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin. Infect. Dis. 33:797805.
100. Mufson, M. A., and, R. J. Stanek. 1999. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 19781997. Am. J. Med. 107:34S43S.
101. Mufson, M. A., and, R. J. Stanek. 2006. Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia. Clin. Infect. Dis. 42:304306.
102. Mundy, L. M.,, P. G. Auwaerter,, D. Oldach,, M. L. Warner,, A. Burton,, E. Vance,, C. A. Gaydos,, J. M. Joseph,, R. Gopalan,, R. D. Moore,, T. C. Quinn,, P. Charache, and, J. G. Bartlett. 1995. Community-acquired pneumonia: impact of immune status. Am. J. Respir. Crit. Care Med. 152:13091315.
103. Murdoch, D. R.,, T. P. Anderson,, K. A. Beynon,, A. Chua,, A. M. Fleming,, R. T. Laing,, G. I. Town,, G. D. Mills,, S. T. Chambers, and, L. C. Jennings. 2003. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J. Clin. Microbiol. 41:6366.
104. Murdoch, D. R.,, R. T. Laing,, G. D. Mills,, N. C. Karalus,, G. I. Town,, S. Mirrett, and, L. B. Reller. 2001. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J. Clin. Microbiol. 39:34953498.
105. Musher, D. M. 2004. A pathogenetic categorization of clinical syndromes caused by Streptococcus pneumoniae, p. 211220. In E. I. Tuomanen et al. (ed.), The Pneumococcus. ASM Press, Washington, DC.
106. Musher, D. M. 2000. Streptococcus pneumoniae, p. 21282147. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases. Churchill Livingston, Philadelphia, PA.
107. Musher, D. M.,, I. Alexandraki,, E. A. Graviss,, N. Yanbeiy,, A. Eid,, L. A. Inderias,, H. M. Phan, and, E. Solomon. 2000. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 79:210221.
108. Musher, D. M.,, R. Montoya, and, A. Wanahita. 2004. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 39:165169.
109. Mykietiuk, A.,, J. Carratala,, A. Dominguez,, A. Manzur,, N. Fernandez-Sabe,, J. Dorca,, F. Tubau,, F. Manresa, and, F. Gudiol. 2006. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 25:457462.
110. Ort, S.,, R. L. Ryan,, G. Barden, and, N. D'Esopo. 1983. Pneumococcal pneumonia in hospitalized patients. JAMA 249:214218.
111. Ortqvist, A.,, A. Grepe,, I. Julander, and, M. Kalin. 1988. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand. J. Infect. Dis. 20:163171.
112. Ortqvist, A.,, M. Kalin,, I. Julander, and, M. A. Mufson. 1993. Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations: Huntington, WV and Stockholm, Sweden. Chest 103:710716.
113. Ortqvist, Å.,, J. Hedlund,, B.-Å. Burman,, E. Elbel,, M. Höfer,, M. Leinonen,, I. Lindblad,, B. Sundelöf,, M. Kalin, andthe Swedish Pneumococcal Vaccination Study Group. 1998. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351:399403.
114. Osmond, D. H.,, D. P. Chin,, J. Glassroth,, P. A. Kvale,, J. M. Wallace,, M. J. Rosen,, L. B. Reichman,, W. K. Poole,, P. C. Hopewell, andthe Pulmonary Complications of HIV Study Group. 1999. Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression. Clin. Infect. Dis. 29:536543.
115. Pachon, J.,, M. D. Prados,, F. Capote,, J. A. Cuello,, J. Garnacho, and, A. Verano. 1990. Severe community-acquired pneumonia. Am. Rev. Respir. Dis. 142:369373.
116. Payeras, A.,, P. Martinez,, J. Mila,, M. Riera,, A. Pareja,, J. Casal, and, N. Matamoros. 2002. Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics. Clin. Exp. Immunol. 130:271278.
117. Perlino, C. A. 1984. Laboratory diagnosis of pneumonia due to Streptococcus pneumoniae. J. Infect. Dis. 150:139144.
118. Pesola, G. R., and, A. Charles. 1992. Pneumococcal bacteremia with pneumonia: mortality in acquired immunodeficiency syndrome. Chest 101:150155.
119. Porath, A.,, F. Schlaeffer,, N. Pick,, M. Leinonen, and, D. Lieberman. 1997. Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:863870.
120. Potgieter, P. D., and, J. M. Hammond. 1996. The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia. Intensive Care Med. 22:13011306.
121. Rathbun, H. K., and, I. Govani. 1967. Mouse inoculation as a means of identifying pneumococci in the sputum. Johns Hopkins Med. J. 120:4648.
122. Redd, S. C.,, G. W. Rutherford,, M. A. Sande,, A. R. Lifson,, W. K. Hadley,, R. R. Facklam, and, J. S. Spika. 1990. The role of human immunodeficiency virus in pneumococcal bacteremia in San Francisco residents. J. Infect. Dis. 162:10121017.
123. Reed, W. W.,, G. S. Byrd,, R. H. Gates, Jr.,, R. S. Howard, and, M. J. Weaver. 1996. Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis. West. J. Med. 165:197204.
124. Roson, B.,, J. Carratala,, R. Verdaguer,, J. Dorca,, F. Manresa, and, F. Gudiol. 2000. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin. Infect. Dis. 31:869874.
125. Ruben, F. L.,, C. W. Norden, and, Y. Korica. 1984. Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. Am. J. Med. 77:10911094.
126. Rudolph, K. M.,, A. J. Parkinson,, C. M. Black, and, L. W. Mayer. 1993. Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia. J. Clin. Microbiol. 31:26612666.
127. Salo, P.,, A. Ortqvist, and, M. Leinonen. 1995. Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J. Infect. Dis. 171:479482.
128. Sangthawan, P.,, S. Chantaratchada,, N. Chanthadisai, and, A. Wattanathum. 2003. Prevalence and clinical significance of community-acquired penicillin-resistant pneumococcal pneumonia in Thailand. Respirology 8:208212.
129. Sanyal, S.,, P. R. Smith,, A. C. Saha,, S. Gupta,, L. Berkowitz, and, P. Homel. 1999. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 160:346348.
130. Sato, N.,, N. Takayanagi,, K. Kurashima,, D. Tokunaga,, H. Matushima,, M. Ubukata,, T. Yanagisawa,, Y. Sugita, and, M. Kanazawa. 2004. [Usefulness of Streptococcus pneumoniae urinary antigen detection kit and the duration and intensity of reactivity with urinary antigen in patients with pneumonia.] Nihon Kokyuki Gakkai Zasshi 42:247252. (In Japanese.)
131. Schneider, R. F., and, M. J. Rosen. 1999. Pneumococcal infections in HIV-infected adults. Semin. Respir. Infect. 14:237242.
132. Schut, R. S.,, L. R. Peterson,, C. Shanholtzer, and, E. N. Janoff. 1994. Erythromycin-resistant pneumococcal endocarditis in a patient treated for community-acquired pneumonia. Infect. Dis. Clin. Pract. 3:108110.
133. Scott, J. A.,, E. L. Marston,, A. J. Hall, and, K. Marsh. 2003. Diagnosis of pneumococcal pneumonia by psaA PCR analysis of lung aspirates from adult patients in Kenya. J. Clin. Microbiol. 41:25542559.
134. Scott, J. A.,, Z. Mlacha,, J. Nyiro,, S. Njenga,, P. Lewa,, J. Obiero,, H. Otieno,, J. S. Sampson, and, G. M. Carlone. 2005. Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A. Clin. Diagn. Lab. Immunol. 12:11951201.
135. Scott, J. A.,, J. Obiero,, A. J. Hall, and, K. Marsh. 2002. Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. J. Infect. Dis. 186:220226.
136. Shariatzadeh, M. R.,, J. Q. Huang,, G. J. Tyrrell,, M. M. Johnson, and, T. J. Marrie. 2005. Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore) 84:147161.
137. Smith, M. D.,, P. Derrington,, R. Evans,, M. Creek,, R. Morris,, D. A. Dance, and, K. Cartwright. 2003. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J. Clin. Microbiol. 41:28102813.
138. Song, J. H.,, S. I. Jung,, H. K. Ki,, M. H. Shin,, K. S. Ko,, J. S. Son,, H. H. Chang,, S. W. Kim,, H. Lee,, Y. S. Kim,, W. S. Oh,, K. R. Peck,, A. Chongthaleong,, M. K. Lalitha,, J. Perera,, T. T. Yee,, F. Jamal,, A. Kamarulzaman,, C. C. Carlos,, T. So, andthe Asian Network for Surveillance of Resistant Pathogens Study Group. 2004. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin. Infect. Dis. 38:15701578.
139. Speets, A. M.,, A. W. Hoes,, Y. van der Graaf,, S. Kalmijn,, A. P. Sachs, and, W. P. Mali. 2006. Chest radiography and pneumonia in primary care: diagnostic yield and consequences for patient management. Eur. Respir. J. 28:933938.
140. Stralin, K.,, M. S. Kaltoft,, H. B. Konradsen,, P. Olcen, and, H. Holmberg. 2004. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J. Clin. Microbiol. 42:36203625.
141. Syrjala, H.,, M. Broas,, I. Suramo,, A. Ojala, and, S. Lahde. 1998. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin. Infect. Dis. 27:358363.
142. Taryle, D. A.,, D. E. Potts,, S. A. Sahn,, D. A. Taryle,, D. E. Potts, and, S. A. Sahn. 1978. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest 74:170173.
143. Tempest, B.,, R. Morgan,, M. Davidson,, B. Eberle, and, R. Oseasohn. 1974. The value of respiratory tract bacteriology in pneumococcal pneumonia among Navajo Indians. Am. Rev. Respir. Dis. 109:577578.
144. Tharpe, J. A.,, H. Russell,, M. Leinonen,, B. D. Plikaytis,, R. F. Breiman,, G. M. Carlone,, E. W. Ades, and, J. S. Sampson. 1998. Comparison of a pneumococcal common protein (PsaA) antibody ELISA and a PsaA immune complex ELISA for detection of pneumococcal serum antibody. Pathobiology 66:7783.
145. Theerthakarai, R.,, W. El-Halees,, M. Ismail,, R. A. Solis, and, M. A. Khan. 2001. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest 119:181184.
146. Tilghman, R. C., and, M. Finland. 1937. Clinical significance of bacteremia in pneumococcal pneumonia. Arch. Intern. Med. 59:602619.
147. Tleyjeh, I. M.,, H. M. Tlaygeh,, R. Hejal,, V. M. Montori, and, L. M. Baddour. 2006. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin. Infect. Dis. 42:788797.
148. Torres, A.,, J. Serra-Batlles,, A. Ferrer,, P. Jimenez,, R. Celis,, E. Cobo, and, R. Rodriguea-Roisin. 1991. Severe community-acquired pneumonia. Am. Rev. Respir. Dis. 144:312318.
149. Torres, J. M.,, O. Cardenas,, A. Vasquez, and, D. Schlossberg. 1998. Streptococcus pneumoniae bacteremia in a community hospital. Chest 113:387390.
150. Trampuz, A.,, A. F. Widmer,, U. Fluckiger,, M. Haenggi,, R. Frei, and, W. Zimmerli. 2004. Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986-2000. Mayo Clin. Proc. 79:604612.
151. Tzeng, D. H.,, Y. L. Lee,, Y. H. Lin,, C. A. Tsai, and, Z. Y. Shi. 2006. Diagnostic value of the Binax NOW assay for identifying a pneumococcal etiology in patients with respiratory tract infection. J. Microbiol. Immunol. Infect. 39:3944.
152. Verenkar, M. P.,, M. J. Pinto,, R. Savio,, N. Virginkar, and, I. Singh. 1993. Bacterial pneumonias–evaluation of various sputum culture methods. J. Postgrad. Med. 39:6062.
153. Watanakunakorn, C., and, T. A. Bailey. 1997. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992–1996. A detailed analysis of 108 cases. Arch. Intern. Med. 157:19651971.
154. Watanakunakorn, C.,, A. Greifenstein,, K. Stroh,, D. G. Jarjoura,, D. Blend,, A. Cugino, and, A. J. Ognibene. 1993. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 103:11521156.
155. Watanuki, Y.,, H. Takahashi,, T. Ogura,, N. Miyazawa,, T. Tomioka, and, S. Odagiri. 2005. [Usefulness of urinary antigen and sputum Gram stain for rapid diagnosis of pneumococcal respiratory infections.] Kansenshogaku Zasshi 79:1319. (In Japanese.)
156. Welte, T.,, W. Petermann,, D. Schurmann,, T. T. Bauer, and, P. Reimnitz. 2005. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clin. Infect. Dis. 41:16971705.
157. Yanagihara, K.,, Y. Otsu,, H. Ohno,, Y. Higashiyama,, Y. Miyazaki,, Y. Hirakata,, K. Tomono,, J. Kadota,, T. Tashiro, and, S. Kohno. 2004. Clinical characteristics of pneumonia caused by penicillin resistant and sensitive Streptococcus pneumoniae in Japan. Intern. Med. 43:10291033.
158. Yang, S.,, S. Lin,, A. Khalil,, C. Gaydos,, E. Nuemberger,, G. Juan,, J. Hardick,, J. G. Bartlett,, P. G. Auwaerter, and, R. E. Rothman. 2005. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J. Clin. Microbiol. 43:32213226.
159. Yu, V. L.,, C. C. Chiou,, C. Feldman,, A. Ortqvist,, J. Rello,, A. J. Morris,, L. M. Baddour,, C. M. Luna,, D. R. Snydman,, M. Ip,, W. C. Ko,, M. B. Chedid,, A. Andremont,, K. P. Klugman, andInternational Pneumococcal Study Group. 2003. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin. Infect. Dis. 37:230237.
160. Ziskind, M. M.,, M. I. Schwarz,, R. B. George,, H. Weill,, J. M. Shames,, S. J. Herbert, and, H. Ichinose. 1970. Incomplete consolidation in pneumococcal lobar pneumonia complicating pulmonary emphysema. Ann. Intern. Med. 72:835839.

Tables

Generic image for table
Table 1

Significant characteristics and considerations distinguishing various studies of clinical predictors of mortality and outcome from pneumococcal infection in adults

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Generic image for table
Table 2

Summary of studies of clinical predictors of mortality from pneumococcal pneumonia and bacteremia in adults

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Generic image for table

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Generic image for table
Table 3

Univariate risks for lethal pneumococcal infection in adults

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Generic image for table
Table 4

Multivariate risks for death from pneumococcal infection in adults

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9
Generic image for table
Table 5

IDSA guidelines for recommended empirical antibiotics for community-acquired pneumonia (2007)

Citation: Rubins J, Boulware D, Janoff E. 2008. Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy, p 117-138. In Siber G, Klugman K, Mäkelä P (ed), Pneumococcal Vaccines. ASM Press, Washington, DC. doi: 10.1128/9781555815820.ch9

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error